Sphingosine 1-phosphate regulates regeneration and fibrosis after liver injury via sphingosine 1-phosphate receptor 2

Journal of Lipid Research

Volumn 50, Issue 3, 2009, Pages 556-564

  Ikeda, Hitoshi ^a   Watanabe, Naoko ^a   Ishii, Isao ^b   Shimosawa, Tatsuo ^a   Kume, Yukio ^a   Tomiya, Tomoaki ^a   Inoue, Yukiko ^a   Nishikawa, Takako ^a   Ohtomo, Natsuko ^a   Tanoue, Yasushi ^a   Iitsuka, Satoko ^a   Fujita, Ryoto ^a   Omata, Masao ^a   Chun, Jerold ^c   Yatomi, Yutaka ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Hepatic myofibroblast; Hepatic stellate cell; Hepatocyte; Liver fibrosis; Liver regeneration

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; AMINOTRANSFERASE; CARBON TETRACHLORIDE; DIMETHYLNITROSAMINE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE 1 PHOSPHATE RECEPTOR 2; UNCLASSIFIED DRUG; CYCLINE; DRUG DERIVATIVE; LYSOPHOSPHOLIPID; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE RECEPTOR 2, MOUSE; SPHINGOSINE 1-PHOSPHATE; SPHINGOSINE-1-PHOSPHATE RECEPTOR-2, MOUSE;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; LIVER CELL; LIVER FIBROSIS; LIVER INJURY; LIVER REGENERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENETICS; INJURY; LIVER; LIVER CIRRHOSIS; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CARBON TETRACHLORIDE; DIMETHYLNITROSAMINE; FEMALE; HEPATOCYTES; LIVER; LIVER CIRRHOSIS; LIVER REGENERATION; LYSOPHOSPHOLIPIDS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTORS, LYSOSPHINGOLIPID; SPHINGOSINE;

EID: 64349089268     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M800496-JLR200     Document Type: Article

References (43)

1. Spiegel, S., and A. H. Merrill, Jr. 1996. Sphingolipid metabolism and cell growth regulation. FASEB J. 10: 1388-1397.
2. Olivera, A., and S. Spiegel. 1993. Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens. Nature. 365: 557-560.
3. Rani, C. S., F. Wang, E. Fuior, A. Berger, J. Wu, T. W. Sturgill, D. Beitner-Johnson, D. LeRoith, L. Varticovski, and S. Spiegel. 1997. Divergence in signal transduction pathways of platelet-derived growth factor (PDGF) and epidermal growth factor (EGF) receptors. Involvement of sphingosine 1-phosphate in PDGF but not EGF signaling. J. Biol. Chem. 272: 10777-10783.
4. Cuvillier, O., G. Pirianov, B. Kleuser, P. G. Vanek, O. A. Coso, S. Gutkind, and S. Spiegel. 1996. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature. 381: 800-803.
5. Edsall, L. C., G. G. Pirianov, and S. Spiegel. 1997. Involvement of sphingosine 1-phosphate in nerve growth factor-mediated neuronal survival and differentiation. J. Neurosci. 17: 6952-6960.
6. Goodemote, K. A., M. E. Mattie, A. Berger, and S. Spiegel. 1995. Involvement of a pertussis toxin-sensitive G protein in the mitogenic signaling pathways of sphingosine 1-phosphate. J. Biol. Chem. 270: 10272-10277.
7. Tosaka, M., F. Okajima, Y. Hashiba, N. Saito, T. Nagano, T. Watanabe, T. Kimura, and T. Sasaki. 2001. Sphingosine 1-phosphate contracts canine basilar arteries in vitro and in vivo: possible role in pathogenesis of cerebral vasospasm. Stroke. 32: 2913-2919.
8. Ohmori, T., Y. Yatomi, M. Osada, F. Kazama, T. Takafuta, H. Ikeda, and Y. Ozaki. 2003. Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2. Cardiovasc. Res. 58: 170-177.
9. Ishii, I., N. Fukushima, X. Ye, and J. Chun. 2004. Lysophospholipid receptors: signaling and biology. Annu. Rev. Biochem. 73: 321-354.
10. Gardell, S. E., A. E. Dubin, and J. Chun. 2006. Emerging medicinal roles for lysophospholipid signaling. Trends Mol. Med. 12: 65-75.
11. Yatomi, Y., F. Ruan, J. Ohta, R. J. Welch, S. Hakomori, and Y. Igarashi. 1995. Quantitative measurement of sphingosine 1-phosphate in biological samples by acylation with radioactive acetic anhydride. Anal. Biochem. 230: 315-320.
12. Pappu, R., S. R. Schwab, I. Cornelissen, J. P. Pereira, J. B. Regard, Y. Xu, E. Camerer, Y. W. Zheng, Y. Huang, J. G. Cyster, et al. 2007. Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science. 316: 295-298.
13. Chun, J. 2007. Immunology. The sources of a lipid conundrum. Science. 316: 208-210.
14. Yang, A. H., I. Ishii, and J. Chun. 2002. In vivo roles of lysophospholipid receptors revealed by gene targeting studies in mice. Biochim. Biophys. Acta. 1582: 197-203.
15. Herr, D. R., N. Grillet, M. Schwander, R. Rivera, U. Muller, and J. Chun. 2007. Sphingosine 1-phosphate (S1P) signaling is required for maintenance of hair cells mainly via activation of S1P2. J. Neurosci. 27: 1474-1478.
16. Ikeda, H., Y. Yatomi, M. Yanase, H. Satoh, H. Maekawa, I. Ogata, Y. Ozaki, Y. Takuwa, S. Mochida, and K. Fujiwara. 2000. Biological activities of novel lipid mediator sphingosine 1-phosphate in rat hepatic stellate cells. Am. J. Physiol. Gastrointest. Liver Physiol. 279: G304-G310.
17. Ikeda, H., K. Nagashima, M. Yanase, T. Tomiya, M. Arai, Y. Inoue, K. Tejima, T. Nishikawa, N. Watanabe, M. Omata, et al. 2004. Sphingosine 1-phosphate enhances portal pressure in isolated perfused liver via S1P2 with Rho activation. Biochem. Biophys. Res. Commun. 320: 754-759.
18. Ikeda, H., H. Satoh, M. Yanase, Y. Inoue, T. Tomiya, M. Arai, K. Tejima, K. Nagashima, H. Maekawa, N. Yahagi, et al. 2003. Antiproliferative property of sphingosine 1-phosphate in rat hepatocytes involves activation of Rho via Edg-5. Gastroenterology. 124: 459-469.
19. Michalopoulos, G. K., and M. C. DeFrances. 1997. Liver regeneration. Science. 276: 60-66.
20. Friedman, S. L. 2000. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem. 275: 2247-2250.
21. Minato, Y., Y. Hasumura, and J. Takeuchi. 1983. The role of fat-storing cells in Disse space fibrogenesis in alcoholic liver disease. Hepatology. 3: 559-566.
22. Rockey, D. C., C. N. Housset, and S. L. Friedman. 1993. Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo. J. Clin. Invest. 92: 1795-1804.
23. Serriere-Lanneau, V., F. Teixeira-Clerc, L. Li, M. Schippers, W. de Wries, B. Julien, J. Tran-Van-Nhieu, S. Manin, K. Poelstra, J. Chun, et al. 2007. The sphingosine 1-phosphate receptor S1P2 triggers hepatic wound healing. FASEB J. 21: 2005-2013.
24. Adachi, M., Y. Osawa, H. Uchinami, T. Kitamura, D. Accili, and D. A. Brenner. 2007. The forkhead transcription factor FoxO1 regulates proliferation and transdifferentiation of hepatic stellate cells. Gastroenterology. 132: 1434-1446.
25. Kojima, N., M. Hori, T. Murata, Y. Morizane, and H. Ozaki. 2007. Different profiles of Ca2+ responses to endothelin-1 and PDGF in liver myofibroblasts during the process of cell differentiation. Br. J. Pharmacol. 151: 816-827.
26. Park, E. J., Y. Z. Zhao, Y. C. Kim, and D. H. Sohn. 2007. Bakuchiol-induced caspase-3-dependent apoptosis occurs through c-Jun NH2-terminal kinase-mediated mitochondrial translocation of Bax in rat liver myofibroblasts. Eur. J. Pharmacol. 559: 115-123.
27. Watson, M. R., K. Wallace, R. G. Gieling, D. M. Manas, E. Jaffray, R. T. Hay, D. A. Mann, and F. Oakley. 2008. NF-kappaB is a critical regulator of the survival of rodent and human hepatic myofibroblasts. J. Hepatol. 48: 589-597.
28. Knittel, T., D. Kobold, B. Saile, A. Grundmann, K. Neubauer, F. Piscaglia, and G. Ramadori. 1999. Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential. Gastroenterology. 117: 1205-1221.
29. Saile, B., N. Matthes, K. Neubauer, C. Eisenbach, H. El-Armouche, J. Dudas, and G. Ramadori. 2002. Rat liver myofibroblasts and hepatic stellate cells differ in CD95-mediated apoptosis and response to TNF-alpha. Am. J. Physiol. Gastrointest. Liver Physiol. 283: G435-G444.
30. Ishii, I., X. Ye, B. Friedman, S. Kawamura, J. J. Contos, M. A. Kingsbury, A. H. Yang, G. Zhang, J. H. Brown, and J. Chun. 2002. Marked perinatal lethality and cellular signaling deficits in mice null for the two sphingosine 1-phosphate (S1P) receptors, S1P (2)/LP(B2)/EDG-5 and S1P(3)/LP(B3)/EDG-3. J. Biol. Chem. 277: 25152-25159.
31. Goparaju, S. K., P. S. Jolly, K. R. Watterson, M. Bektas, S. Alvarez, S. Sarkar, L. Mel, I. Ishii, J. Chun, S. Milstien, et al. 2005. The S1P2 receptor negatively regulates platelet-derived growth factor-induced motility and proliferation. Mol. Cell. Biol. 25: 4237-4249.
32. Means, C. K., C. Y. Xiao, Z. Li, T. Zhang, J. H. Omens, I. Ishii, J. Chun, and J. H. Brown. 2007. Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 292: H2944-H2951.
33. Simeonova, P. P., R. M. Gallucci, T. Hulderman, R. Wilson, C. Kommineni, M. Rao, and M. I. Luster. 2001. The role of tumor necrosis factor-alpha in liver toxicity, inflammation, and fibrosis induced by carbon tetrachloride. Toxicol. Appl. Pharmacol. 177: 112-120.
34. Kanno, K., S. Tazuma, and K. Chayama. 2003. AT1A-deficient mice show less severe progression of liver fibrosis induced by CCl(4). Biochem. Biophys. Res. Commun. 308: 177-183.
35. Morrison, V., and J. Ashby. 1994. Reconciliation of five negative and four positive reports of the activity of dimethylnitrosamine in the mouse bone marrow micronucleus assay. Mutagenesis. 9: 361-365.
36. Jin, Y. L., H. Enzan, N. Kuroda, Y. Hayashi, H. Nakayama, Y. H. Zhang, M. Toi, E. Miyazaki, M. Hiroi, L. M. Guo, et al. 2003. Tissue remodeling following submassive hemorrhagic necrosis in rat livers induced by an intraperitoneal injection of dimethylnitrosamine. Virchows Arch. 442: 39-47.
37. Bedossa, P., and T. Poynard. 1996. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 24: 289-293.
38. Caballero, T., A. Perez-Milena, M. Masseroli, F. O'Valle, F. J. Salmeron, R. M. Del Moral, and G. Sanchez-Salgado. 2001. Liver fibrosis assessment with semiquantitative indexes and image analysis quantification in sustained-responder and non-responder interferon-treated patients with chronic hepatitis C. J. Hepatol. 34: 740-747.
39. Rockey, D. C., J. K. Boyles, G. Gabbiani, and S. L. Friedman. 1992. Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J. Submicrosc. Cytol. Pathol. 24: 193-203.
40. Sanchez, T., T. Estrada-Hernandez, J. H. Paik, M. T. Wu, K. Venkataraman, V. Brinkmann, K. Claffey, and T. Hla. 2003. Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability. J. Biol. Chem. 278: 47281-47290.
41. Chae, S. S., J. H. Paik, H. Furneaux, and T. Hla. 2004. Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference. J. Clin. Invest. 114: 1082-1089.
42. LaMontagne, K., A. Littlewood-Evans, C. Schnell, T. O'Reilly, L. Wyder, T. Sanchez, B. Probst, J. Butler, A. Wood, G. Liau, et al. 2006. Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization. Cancer Res. 66: 221-231.
43. Sanna, M.G., S. K. Wang, P. J. Gonzalez-Cabrera, A. Don, D. Marsolais, M. P. Matheu, S. H. Wei, I. Parker, E. Jo, W. C. Cheng, et al. 2006. Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo. Nat. Chem. Biol. 2: 434-441.